AstraZeneca Drug List1

S.No. Company Name Short Description No of Drugs Company Drug Price Action
1 AstraZenecaAstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal and Metabolism, and Respiratory and Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.560.00BUYYour Query
S.No. Updated On Drug Price in USD Action
1Mar, 2020Lynparza Drug Sales & Forecast

AstraZeneca drug Lynparza became the world’s ¬first approved PARP inhibitor in 2014. Initially indicated for the treatment of ovarian cancer, in 2017, ....

20.00READBUY Your Query
2Mar, 2020Imfinzi Drug Sales & Forecast

AstraZeneca drug Imfinzi is approved for lung and bladder cancer in 2017. Imfinzi, a human mAb that binds to PD-L1 and blocks the interaction of PD-L1 wit....

20.00READBUY Your Query
3Mar, 2020Crestor Drug Sales & Forecast

AstraZeneca drug Crestor is approved in more than 115 countries for the treatment of dyslipidaemia and hypercholesterolaemia. MNG Tracker report title “....

20.00READBUY Your Query
4Mar, 2020Tagrisso Drug Sales & Forecast

AstraZeneca drug Tagrisso is approved for lung cancer in 2015. Tagrisso is a best-in-class, highly selective, irreversible inhibitor of the activating sen....

20.00READBUY Your Query
5Mar, 2020Brilinta/Brilique Drug Sales & Forecast

Brilinta/Brilique (ticagrelor) is an oral antiplatelet for acute coronary syndromes (ACS). Brilinta/Brilique, one of AstraZeneca Growth Platforms, is an o....

20.00READBUY Your Query